PDE4B and inflammatory bowel disease: Because high levels of PDE4B are present in UC patients, we provide the basis for a greater understanding of inflammatory signaling in UC, suggesting that miR-369-3p, by ameliorating inflammatory conditions, could be used as a new therapeutic approach to inflammatory bowel disease.